Cigna (CI) Tops Q3 EPS by 8c; Updates FY15 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
UBS Reiterates Buy on Cigna Corp. (CI) Following 3Q
November 9, 2015 10:54 AM ESTUBS reiterated a Buy rating on CIGNA (NYSE: CI), and cut the price target to $172.00 (from $175.00), following the company's 3Q earnings report. For 2016, Cigna expects to maintain its public exchange footprint. Cigna participated in limited markets in eight states for 2015, and the company is... More
Positive Operating Execution and SG&A Improvement Drives EPS Beat For Cigna Corp. (CI); Wedbush Remains Neutral
November 9, 2015 8:01 AM ESTWedbush maintained a Neutral rating on CIGNA (NYSE: CI), and cut the price target to $175.00 (from $186.00), following the company's 3Q15 earnings report. Adjusted EPS of $2.28, vs. consensus of $2.20, was driven by positive operating execution with better than expected SG&A improvement. 2015 EPS guidance was raised to $8.40-8.60 from $8.30-8.60 vs. consensus of $8.62.
Analyst Sarah James commented, "Adjusted EPS of $2.28 vs.... More
Health insurer Cigna reports better-than-expected profit
November 6, 2015 6:14 AM EST(Reuters) - Health insurer Cigna Corp (NYSE: CI) reported a better-than-expected quarterly profit, helped by higher enrollments in its government plans and favorable medical costs.
Cigna, which agreed to be bought by larger rival Anthem Inc (NYSE: ANTM) in July, also raised the low end of its forecast for full-year adjusted earnings to $8.40 per share from... More
